Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

19
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/20/2014 11/21/2014 11/24/2014 11/25/2014 11/26/2014 Date
3.25(c) 3.7(c) 3.84(c) 3.59(c) 3.7 Last
5 541 246 18 360 473 13 317 410 11 261 566 5 331 646 Volume
+4.50% +13.85% +3.78% -6.51% +3.06% Change
More quotes
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
Surperformance© rating of Geron Corporation
Trading Rating : Investor Rating :
More about the company
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 24,6 M
EBIT 2014 -13,6 M
Net income 2014 -12,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 1,38 M
EBIT 2015 -43,2 M
Net income 2015 -42,9 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 22,9x
Capi. / Sales 2015 409x
Capitalization 564 M
More Financials
Latest news on GERON CORPORATION
11/18 GERON : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
11/14 GERON : to Present at the Stifel Healthcare Conference
11/14 GERON : Announces Global Strategic Collaboration with Janssen to Develop and Com..
11/13 JOHNSON & JOHNSON : Geron could get $935M in blood disorder drug deal
11/13 GERON : Entry into a Material Definitive Agreement, Other Events, Financial Stat..
11/13 GERON : Announces Global Strategic Collaboration with Janssen to Develop and Com..
11/06 GERON : Announces Presentations at American Society of Hematology Annual Meeting
11/03 GERON : Announces Removal of Full Clinical Hold on Imetelstat IND
09/05 Leading Health Care Stock for Small-Cap Stars is Stereotaxis Inc (STXS) for S..
08/11 GERON : Reports Second Quarter 2014 Financial Results
08/05 GERON : to Assume Sponsorship of Myelofibrosis IST and IND
08/05 GERON : Entry into a Material Definitive Agreement, Other Events (form 8-K)
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF